Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges.

Kohaar I, Petrovics G, Srivastava S.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1813. doi: 10.3390/ijms20081813. Review.

2.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.

Petrovics G, Price DK, Lou H, Chen Y, Garland L, Bass S, Jones K, Kohaar I, Ali A, Ravindranath L, Young D, Cullen J, Dorsey TH, Sesterhenn IA, Brassell SA, Rosner IL, Ross D, Dahut W, Ambs S, Figg WD, Srivastava S, Dean M.

Prostate Cancer Prostatic Dis. 2018 Dec 12. doi: 10.1038/s41391-018-0114-1. [Epub ahead of print]

PMID:
30542053
3.

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, Cheng J, Dalgard CL, Zhang S, Csabai I, Kagan J, Takeda D, Loda M, Srivastava S, Scherf M, Seifert M, Gaiser T, McLeod DG, Szallasi Z, Ebner R, Werner T, Sesterhenn IA, Freedman M, Dobi A, Srivastava S.

EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec.

4.

Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer.

Mishra A, Kumar R, Tyagi A, Kohaar I, Hedau S, Bharti AC, Sarker S, Dey D, Saluja D, Das B.

Ecancermedicalscience. 2015 Apr 23;9:525. doi: 10.3332/ecancer.2015.525. eCollection 2015.

5.

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.

Fu YP, Kohaar I, Moore LE, Lenz P, Figueroa JD, Tang W, Porter-Gill P, Chatterjee N, Scott-Johnson A, Garcia-Closas M, Muchmore B, Baris D, Paquin A, Ylaya K, Schwenn M, Apolo AB, Karagas MR, Tarway M, Johnson A, Mumy A, Schned A, Guedez L, Jones MA, Kida M, Hosain GM, Malats N, Kogevinas M, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Wu X, Purdue M, Andriole GL Jr, Grubb RL 3rd, Black A, Landi MT, Caporaso NE, Vineis P, Siddiq A, Bueno-de-Mesquita HB, Trichopoulos D, Ljungberg B, Severi G, Weiderpass E, Krogh V, Dorronsoro M, Travis RC, Tjønneland A, Brennan P, Chang-Claude J, Riboli E, Prescott J, Chen C, De Vivo I, Govannucci E, Hunter D, Kraft P, Lindstrom S, Gapstur SM, Jacobs EJ, Diver WR, Albanes D, Weinstein SJ, Virtamo J, Kooperberg C, Hohensee C, Rodabough RJ, Cortessis VK, Conti DV, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Haiman CA, Cussenot O, Cancel-Tassin G, Roupret M, Comperat E, Porru S, Carta A, Pavanello S, Arici C, Mastrangelo G, Grossman HB, Wang Z, Deng X, Chung CC, Hutchinson A, Burdette L, Wheeler W, Fraumeni J Jr, Chanock SJ, Hewitt SM, Silverman DT, Rothman N, Prokunina-Olsson L.

Cancer Res. 2014 Oct 15;74(20):5808-18. doi: 10.1158/0008-5472.CAN-14-1531.

6.

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR.

Nat Genet. 2013 Feb;45(2):164-71. doi: 10.1038/ng.2521. Epub 2013 Jan 6.

7.

Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.

Kohaar I, Porter-Gill P, Lenz P, Fu YP, Mumy A, Tang W, Apolo AB, Rothman N, Baris D, Schned AR, Ylaya K, Schwenn M, Johnson A, Jones M, Kida M, Silverman DT, Hewitt SM, Moore LE, Prokunina-Olsson L.

J Natl Cancer Inst. 2013 Jan 2;105(1):69-73. doi: 10.1093/jnci/djs458. Epub 2012 Dec 23.

8.

Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.

Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, Baris D, Mumy A, Albanes D, Purdue MP, Hutchinson A, Carrato A, Tardón A, Serra C, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Diver WR, Gapstur SM, Thun MJ, Virtamo J, Chanock SJ, Fraumeni JF Jr, Silverman DT, Wu X, Real FX, Prokunina-Olsson L.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4974-9. doi: 10.1073/pnas.1202189109. Epub 2012 Mar 13.

9.

Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver.

O'Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, Schadt EE, Prokunina-Olsson L.

Genes Immun. 2011 Sep;12(6):428-33. doi: 10.1038/gene.2011.11. Epub 2011 Feb 24.

10.

NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.

Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L.

Mol Cancer. 2010 May 19;9:113. doi: 10.1186/1476-4598-9-113.

11.

Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.

Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L.

J Virol. 2010 Jul;84(14):6987-94. doi: 10.1128/JVI.00196-10. Epub 2010 May 12.

12.

Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population.

Kohaar I, Kumar J, Thakur N, Hussain S, Niyaz MK, Das BC, Sengupta S, Bharadwaj M.

Biomarkers. 2010 Feb;15(1):61-8. doi: 10.3109/13547500903295881.

PMID:
19793004
13.

Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.

Thakur N, Hussain S, Kohaar I, Tabassum R, Nasare V, Tiwari P, Batra S, Bhambhani S, Das BC, Basir SF, Bharadwaj D, Bharadwaj M.

Biomarkers. 2009 Jun;14(4):219-25. doi: 10.1080/13547500902825274.

PMID:
19489683
14.

Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population.

Singhal S, Kohaar I, Bharadwaj M, Shukla DK, Das BC, Kar P.

Dig Dis Sci. 2010 Apr;55(4):1106-12. doi: 10.1007/s10620-009-0799-z. Epub 2009 Apr 24.

PMID:
19390969
15.

Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.

Kohaar I, Hussain S, Thakur N, Tiwari P, Nasare V, Batra S, Singh V, Bhambani S, Das BC, Sarkar DP, Bharadwaj M.

Hum Immunol. 2009 Apr;70(4):222-9. doi: 10.1016/j.humimm.2009.01.003. Epub 2009 Jan 18.

PMID:
19272325
16.

Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target.

Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P.

Appl Immunohistochem Mol Morphol. 2009 Jul;17(4):282-5. doi: 10.1097/PAI.0b013e3181906f6d.

PMID:
19077906
17.

Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.

Neyaz MK, Kumar RS, Hussain S, Naqvi SH, Kohaar I, Thakur N, Kashyap V, Das BC, Husain SA, Bharadwaj M.

Biomarkers. 2008 Sep;13(6):597-606. doi: 10.1080/13547500802078859.

PMID:
18608185
18.

Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.

Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M.

Breast Cancer Res Treat. 2009 Mar;114(2):347-55. doi: 10.1007/s10549-008-0006-5. Epub 2008 Apr 14.

PMID:
18409070
19.

TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population.

Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M.

Cell Oncol. 2007;29(3):249-56.

Supplemental Content

Loading ...
Support Center